CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Are you undergoing treatment for Congestive Heart Failure?

Purpose

Patients may be entered in the study who are>18 years of age with at least a 30-day history of NYHA Class II to IV HF and and any documented left ventricular ejection fraction within a year prior to screening and signs of volume overload.

Patient Inclusion Criteria:

  • History of chronic CHF requiring standard HF treatment including diuretics for a minimum of 30 days.

Patient Exclusion Criteria:

  • Heart attack or stroke within 30 days prior to screening.
  • Clinically significant valvular disease

To Learn more

CW ID:164006
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

Karen Renaud, Study Coordinator
Tampa Clinical Research
4290 W. Linebaugh Avenue
Tampa, FL 33624
Phone: 813-960-7070
Fax: 813-960-7979

View Map

Research Center Information: Tampa Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.